Stock Research for AMBS


Featured Broker: Ally Invest

Get the due diligence for another stock.


AMBS Stock Chart & Research Data

The AMBS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AMBS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AMBS Due diligence Resources & Stock Charts

The AMBS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AMBS Detailed Price Forecast - CNN Money CNN View AMBS Detailed Summary - Google Finance
Yahoo View AMBS Detailed Summary - Yahoo! Finance Zacks View AMBS Stock Research & Analysis -

Stock Analysis

TradeIdeas View AMBS Trends & Analysis - Trade-Ideas Barrons View AMBS Major Holders - Barrons
NASDAQ View AMBS Call Transcripts - NASDAQ Seeking View AMBS Breaking News & Analysis - Seeking Alpha
Spotlight View AMBS Annual Report - OTC Report View AMBS OTC Short Report -
TradeKing View AMBS Fundamentals - TradeKing Charts View AMBS SEC Filings - Bar Chart
WSJ View Historical Prices for AMBS - The WSJ Morningstar View Performance/Total Return for AMBS - Morningstar
MarketWatch View the Analyst Estimates for AMBS - MarketWatch CNBC View the Earnings History for AMBS - CNBC
StockMarketWatch View the AMBS Earnings - StockMarketWatch MacroAxis View AMBS Buy or Sell Recommendations - MacroAxis
Bullish View the AMBS Bullish Patterns - American Bulls Short Pains View AMBS Short Pain Metrics -

Social Media Mentions

StockTwits View AMBS Stock Mentions - StockTwits PennyStocks View AMBS Stock Mentions - PennyStockTweets
Twitter View AMBS Stock Mentions - Twitter Invest Hub View AMBS Investment Forum News - Investor Hub
Yahoo View AMBS Stock Mentions - Yahoo! Message Board Seeking Alpha View AMBS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AMBS - Insider Cow View Insider Transactions for AMBS - Insider Cow
CNBC View AMBS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AMBS - OTC Markets
Yahoo View Insider Transactions for AMBS - Yahoo! Finance NASDAQ View Institutional Holdings for AMBS - NASDAQ

Stock Charts

FinViz View AMBS Stock Insight & Charts - StockCharts View AMBS Investment Charts -
BarChart View AMBS Stock Overview & Charts - BarChart Trading View View AMBS User Generated Charts - Trading View

Latest Financial News for AMBS

MANF Therapeutics Receives Notices of Allowance Covering MANF Use as Treatment for Parkinson's in Europe and Diabetes in Japan
Posted on Thursday January 17, 2019

New York, NY, Jan. 17, 2019 -- via NEWMEDIAWIRE -- MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK: AMBS) in pre-clinical development.

MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark Office Covering the Use of MANF or CDNF as a Treatment for Glaucoma, Macular Degeneration and Retinitis Pigmentosa
Posted on Tuesday January 15, 2019

New York, NY, Jan. 15, 2019 -- via NEWMEDIAWIRE -- MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK: AMBS) in pre-clinical development.

Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries
Posted on Friday January 11, 2019

Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries

Amarantus Provides 2019 Roadmap
Posted on Monday January 07, 2019

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the "Company," or AMBS), a US-based, JLABS-alumnus biotechnology holding company developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today provided an update on its turnaround plan as senior management prepares to attend key events surrounding the JP Morgan Healthcare Conference in San Francisco. To this end, we have been working on executing partnerships and asset sales, while simultaneously negotiating down existing obligations.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.